{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:53Z","timestamp":1790870033092,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1136\/ard.2008.100677","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T01:33:59Z","timestamp":1232415239000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study"],"prefix":"10.1016","volume":"69","author":[{"given":"V","family":"Nell-Duxneuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Machold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Eberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Heinzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hoefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.100677_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2008.100677_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ard.2003.010298","article-title":"Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.","volume":"63","author":"Van Aken","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib3","first-page":"2208","article-title":"Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5\u2013year follow-up of a prospective double blind placebo controlled study.","volume":"22","author":"Egsmose","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.100677_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/40.11.1211","article-title":"The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?","volume":"40","author":"Quinn","year":"2001","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2008.100677_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.61.7.630","article-title":"Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.","volume":"61","author":"Aletaha","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib6","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","article-title":"New therapies for treatment of rheumatoid arthritis.","volume":"370","author":"Smolen","year":"2007","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.100677_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/ard.61.4.290","article-title":"Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.","volume":"61","author":"Emery","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.100677_bib9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1136\/ard.2008.100677_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","article-title":"Autoantibodies in rheumatoid arthritis and their clinical significance.","volume":"4","author":"Steiner","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2008.100677_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib12","first-page":"2074","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.","volume":"29","author":"Jansen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.100677_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/000456303763046049","article-title":"Why do general practitioners request rheumatoid factor? A study of symptoms, requesting patterns and patient outcome.","volume":"40","author":"Sinclair","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1136\/ard.2008.100677_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.169.2.1068","article-title":"Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.","volume":"169","author":"Fritsch","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard.2008.100677_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials.","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.100677_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/028418517701800415","article-title":"Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.","volume":"18","author":"Larsen","year":"1977","journal-title":"Acta Radiol Diagn (Stockh)"},{"key":"10.1136\/ard.2008.100677_bib17","first-page":"264","article-title":"Using the Larsen index to assess radiographic progression in rheumatoid arthritis.","volume":"27","author":"Kirwan","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.100677_bib18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACo trial group.","volume":"353","author":"Mottonen","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.100677_bib19","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.","volume":"343","author":"Bathon","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.100677_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.57.2.88","article-title":"Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study.","volume":"57","author":"Munro","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","article-title":"Prognostic laboratory markers of joint damage in rheumatoid arthritis.","volume":"64","author":"Lindqvist","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.","volume":"65","author":"Berglin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-006-0275-5","article-title":"Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.","volume":"26","author":"Agrawal","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2008.100677_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/03009740600958538","article-title":"Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.","volume":"36","author":"Nikolaisen","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2008.100677_bib25","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.20659","article-title":"Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.100677_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.100677_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/rheumatology\/kel418","article-title":"Classification criteria for rheumatoid arthritis\u2013time to abandon rheumatoid factor?","volume":"46","author":"Symmons","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.100677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:14:48Z","timestamp":1737249288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724196744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0003496724196744"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.100677","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.100677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}